血管年龄:评估方法,临床应用和未来方向的叙述性审查
Zisu Yang1, Xiaobo Wang2, Lihua Li1,3
1Department of Gerontology, The First Affiliated Hospital of Dali University, Jiashibo Road 32, Dali, 671000, Yunnan Province, China.
International journal of cardiology. Cardiovascular risk and prevention
|February 25, 2026
概括
血管年龄 (VA) 比时间年龄更好地衡量心血管健康,改善风险评估和患者沟通. 本综述探讨VA评估方法及其用于预防心血管疾病的临床应用.
科学领域:
- 心脏病学 心脏病学
- 血管生物学 血管生物学
- 预防医学 预防医学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 传统的心血管疾病风险模型与中等风险分层斗争.
- 血管年龄 (VA) 提供了血管健康的生物指标,有可能改善风险评估和患者参与.
研究的目的:
- 审查目前评估血管年龄 (VA) 的方法.
- 讨论VA在心血管疾病 (CVD) 风险分层中的临床进展和应用.
- 探索新兴技术和VA实施的未来方向.
主要方法:
- 系统审查关于VA评估的文献.
- 分析包括动脉硬度 (例如,脉冲波速度),血管结构 (例如,动脉内膜介质厚度,冠状动脉分) 和血管功能等技术.
- 纳入新兴的基于人工智能的方法 (例如,从光电解剖学,视网膜图像的深度学习).
主要成果:
- VA整合了多种风险因素和累积血管损伤.
- VA有助于对中等风险个体进行分层,并增强医生与患者之间的沟通.
- 应用包括个性化治疗指导和在特定人群中使用 (糖尿病,类风湿性关节炎).
结论:
- 血管年龄代表了提高心血管疾病风险评估和管理的有希望的工具.
- 方法,参考值和成本效益研究的标准化对于广泛的临床采用是必要的.
- 未来的研究应该专注于技术创新和临床试验验证,以实现VA的实际实施.
相关概念视频
The Effect of Aging on Tissues
4.0K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.0K
Pharmacodynamics in Geriatric Patients: Effects of Age
278
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
278
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
514
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
514
Assessment of the Cardiovascular System I: Subjective Data
976
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
976
Assessment of the Cardiovascular System II: Inspection
973
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Head and Neck
973


